Jose Arribas
Jose Arribas
Hospital La Paz
Verified email at salud.madrid.org
Title
Cited by
Cited by
Year
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant, E DeJesus, JR Arribas, AL Pozniak, B Gazzard, RE Campo, ...
New England Journal of Medicine 354 (3), 251-260, 2006
11132006
Lopinavir–ritonavir versus nelfinavir for the initial treatment of HIV infection
S Walmsley, B Bernstein, M King, J Arribas, G Beall, P Ruane, M Johnson, ...
New England Journal of Medicine 346 (26), 2039-2046, 2002
7952002
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study
HJ Stellbrink, C Orkin, JR Arribas, J Compston, J Gerstoft, ...
Clinical Infectious Diseases 51 (8), 963-972, 2010
3962010
Evaluation of convalescent plasma for Ebola virus disease in Guinea
J Van Griensven, T Edwards, X de Lamballerie, MG Semple, P Gallian, ...
New England Journal of Medicine 374 (1), 33-42, 2016
3422016
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis
JR Arribas, AL Pozniak, JE Gallant, E DeJesus, B Gazzard, RE Campo, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (1), 74-78, 2008
3102008
Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study
A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ...
The Journal of infectious diseases 210 (3), 354-362, 2014
2902014
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and …
AL Pozniak, JE Gallant, E DeJesus, JR Arribas, B Gazzard, RE Campo, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (5), 535-540, 2006
2782006
Clinical management of Ebola virus disease in the United States and Europe
TM Uyeki, AK Mehta, RT Davey Jr, AM Liddell, T Wolf, P Vetter, ...
New England Journal of Medicine 374 (7), 636-646, 2016
2752016
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised …
J van Lunzen, F Maggiolo, JR Arribas, A Rakhmanova, P Yeni, B Young, ...
The Lancet infectious diseases 12 (2), 111-118, 2012
2732012
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
M Pérez-Olmeda, M Núñez, M Romero, J González, A Castro, JR Arribas, ...
Aids 17 (7), 1023-1028, 2003
2662003
Cytomegalovirus encephalitis
JR Arribas, GA Storch, DB Clifford, AC Tselis
Annals of internal medicine 125 (7), 577-587, 1996
2601996
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial
AR Lifson, J Neuhaus, JR Arribas, M van den Berg-Wolf, AM Labriola, ...
American journal of public health 100 (10), 1896-1903, 2010
2522010
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active …
A Mills, JR Arribas, J Andrade-Villanueva, G DiPerri, J Van Lunzen, ...
The Lancet Infectious Diseases 16 (1), 43-52, 2016
2362016
The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
JR Arribas, A Horban, J Gerstoft, G Fätkenheuer, M Nelson, N Clumeck, ...
Aids 24 (2), 223-230, 2010
2162010
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial
JJ Eron Jr, JK Rockstroh, J Reynes, J Andrade-Villanueva, ...
The Lancet infectious diseases 11 (12), 907-915, 2011
2082011
Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical …
JR Arribas, F Pulido, R Delgado, A Lorenzo, P Miralles, A Arranz, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 280-287, 2005
2002005
Assessment of second-line antiretroviral regimens for HIV therapy in Africa
NI Paton, C Kityo, A Hoppe, A Reid, A Kambugu, A Lugemwa, ...
New England journal of medicine 371 (3), 234-247, 2014
1812014
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
F Pulido, JR Arribas, R Delgado, E Cabrero, J González-García, ...
Aids 22 (2), F1-F9, 2008
1792008
Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 …
F Raffi, AG Babiker, L Richert, JM Molina, EC George, A Antinori, ...
The Lancet 384 (9958), 1942-1951, 2014
1762014
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in …
P Cahn, J Andrade-Villanueva, JR Arribas, JM Gatell, JR Lama, M Norton, ...
The Lancet Infectious Diseases 14 (7), 572-580, 2014
1582014
The system can't perform the operation now. Try again later.
Articles 1–20